25 results on '"Agostinis C."'
Search Results
2. Evaluation of levels, specificity and pathophysiology of anti-C1q autoantibodies in pregnancy
- Author
-
Agostinis, C., primary, Zito, G., additional, Toffoli, M., additional, Balduit, A., additional, Mangogna, A., additional, Belmonte, B., additional, Romano, F., additional, Stampalija, T., additional, Salviato, T., additional, Defendi, F., additional, Di Simone, N., additional, Kishore, U., additional, Giuseppe, R., additional, and Bulla, R., additional
- Published
- 2023
- Full Text
- View/download PDF
3. Effective revascularization of non-healing wounds by the human Stromal Vascular Fraction relies on direct cell integration and paracrine signals
- Author
-
Vuerich, R, primary, Groppa, E, additional, Vodret, S, additional, Ring, N, additional, Stocco, C, additional, Bossi, F, additional, Agostinis, C, additional, Colliva, A, additional, Simoncello, F, additional, Benvenuti, F, additional, Agnelli, A, additional, Dore, F, additional, Bulla, R, additional, Papa, G, additional, and Zacchigna, S, additional
- Published
- 2022
- Full Text
- View/download PDF
4. SARS-CoV-2 modulates virus receptor expression in placenta and can induce trophoblast fusion, inflammation and endothelial permeability
- Author
-
Chiara Agostinis, Miriam Toffoli, Mariagiulia Spazzapan, Andrea Balduit, Gabriella Zito, Alessandro Mangogna, Luisa Zupin, Tiziana Salviato, Serena Maiocchi, Federico Romano, Sergio Crovella, Francesco Fontana, Luca Braga, Marco Confalonieri, Giuseppe Ricci, Uday Kishore, Roberta Bulla, 1., Agostinis C, Toffoli, M, Spazzapan, M, Balduit, A, Zito, G, Mangogna, A, Zupin, L, Salviato, T, Maiocchi, S, Romano, F, Crovella, S, Fontana, F, Braga, L, Confalonieri, M, Ricci, G, Kishore, U, and Bulla, R
- Subjects
Inflammation ,SARS-CoV-2 ,Placenta ,Immunology ,COVID-19 ,ACE2 ,Permeability ,Trophoblasts ,Pre-Eclampsia ,Pregnancy ,Spike Glycoprotein, Coronavirus ,CD147 ,TMPRSS2 ,pregnancy ,Cytokines ,Humans ,Premature Birth ,Receptors, Virus ,Immunology and Allergy ,Female ,Angiotensin-Converting Enzyme 2 ,Pregnancy Complications, Infectious - Abstract
SARS-CoV-2 is a devastating virus that induces a range of immunopathological mechanisms including cytokine storm, apoptosis, inflammation and complement and coagulation pathway hyperactivation. However, how the infection impacts pregnant mothers is still being worked out due to evidence of vertical transmission of the SARS-CoV-2, and higher incidence of pre-eclampsia, preterm birth, caesarian section, and fetal mortality. In this study, we assessed the levels of the three main receptors of SARS-CoV-2 (ACE2, TMPRSS2 and CD147) in placentae derived from SARS-CoV-2 positive and negative mothers. Moreover, we measured the effects of Spike protein on placental cell lines, in addition to their susceptibility to infection. SARS-CoV-2 negative placentae showed elevated levels of CD147 and considerably low amount of TMPRSS2, making them non-permissive to infection. SARS-CoV-2 presence upregulated TMPRSS2 expression in syncytiotrophoblast and cytotrophoblast cells, thereby rendering them amenable to infection. The non-permissiveness of placental cells can be due to their less fusogenicity due to infection. We also found that Spike protein was capable of inducing pro-inflammatory cytokine production, syncytiotrophoblast apoptosis and increased vascular permeability. These events can elicit pre-eclampsia-like syndrome that marks a high percentage of pregnancies when mothers are infected with SARS-CoV-2. Our study raises important points relevant to SARS-CoV-2 mediated adverse pregnancy outcomes.
- Published
- 2022
5. Differential Capability of Clinically Employed Dermal Regeneration Scaffolds to Support Vascularization for Tissue Bioengineering
- Author
-
Chiara Stocco, Serena Zacchigna, Giovanni Papa, Roberta Bulla, Chiara Agostinis, Mariagiulia Spazzapan, Alessandro Mangogna, Andrea Balduit, Giuseppe Ricci, Roman Vuerich, Agostinis, C., Spazzapan, M., Vuerich, R., Balduit, A., Stocco, C., Mangogna, A., Ricci, G., Papa, G., Zacchigna, S., and Bulla, R.
- Subjects
Scaffold ,Angiogenesis ,QH301-705.5 ,Medicine (miscellaneous) ,Wound healing ,Context (language use) ,wound healing ,Article ,General Biochemistry, Genetics and Molecular Biology ,angiogenesis ,Acellular dermal matrices (ADMs) ,Chronic wounds ,Endothelial cells ,Endothelial cell ,In vivo ,Medicine ,Inosculation ,Biology (General) ,Chronic wound ,acellular dermal matrices (ADMs) ,integumentary system ,business.industry ,Regeneration (biology) ,endothelial cells ,Angiogenesi ,Wound dressing ,chronic wounds ,business ,Biomedical engineering - Abstract
The loss of skin integrity has always represented a major challenge for clinicians dealing with dermal defects, such as ulcers (diabetic, vascular and chronic), postoncologic resections (i.e., radical vulvectomy) or dermatologic disorders. The introduction in recent decades of acellular dermal matrices (ADMs) supporting the repair and restoration of skin functionality represented a significant step toward achieving clean wound repair before performing skin grafts. Hard-to-heal ulcers generally depend on local ischemia and nonadequate vascularization. In this context, one possible innovative approach could be the prevascularization of matrices with vessel-forming cells (inosculation). This paper presents a comparative analysis of the most widely used dermal templates, i.e., Integra® Bilayer Matrix Wound Dressing, PELNAC®, PriMatrix® Dermal Repair Scaffold, Endoform® Natural Dermal Template, and Myriad Matrix®, testing their ability to be colonized by human adult dermal microvascular endothelial cells (ADMECs) and to induce and support angiogenesis in vitro and in vivo. By in vitro studies, we demonstrated that Integra® and PELNAC® possess superior pro-adhesive and pro-angiogenetic properties. Animal models allowed us to demonstrate the ability of preseeded ADMECs on Integra® to promote the engraftment, integration and vascularization of ADMs at the site of application.
- Published
- 2021
6. Case 328: Brown Tumor in Hyperparathyroidism Due to Parathyroid Adenoma.
- Author
-
Agostinis C and Lupi E
- Subjects
- Humans, Female, Middle Aged, Hyperparathyroidism diagnostic imaging, Hyperparathyroidism complications, Adenoma diagnostic imaging, Adenoma complications, Diagnosis, Differential, Parathyroid Neoplasms diagnostic imaging, Parathyroid Neoplasms complications
- Abstract
History: A 45-year-old female patient with diffuse osteoarticular pain, particularly low back pain, was referred by a rheumatologist for an updated radiologic evaluation. The patient had experienced these symptoms for many years and was diagnosed with human leukocyte antigen B27-negative spondyloarthritis approximately 11 years prior, based on findings of bilateral erosive sacroiliitis at pelvic radiography and bone scintigraphy with technetium 99m (
99m Tc) methylene diphosphonate. After 3 years of treatment with a tumor necrosis factor-α inhibitor (adalimumab), which was effective for pain, the patient was lost to follow-up. At the current presentation, approximately 8 years after being lost to follow-up, the patient presented with worsening low back pain. The presence of nonobstructing kidney stones on US images confounded the underlying cause of worsening pain. The patient also experienced fatigue and depressed mood. Routine blood tests revealed a normal blood cell count, creatinine level of 0.64 mg/dL (56.58 μmol/L) (normal range, 0.30-1.1 mg/dL [26.52-97.24 μmol/L]), C-reactive protein level of 1.1 mg/dL (normal, <1 mg/dL), and vitamin D level of 21 ng/mL (52.42 nmol/L) (normal range, 30-100 ng/mL [74.88-249.60 nmol/L]). Noncontrast MRI of the thoracic and lumbar spine, MRI of the sacroiliac joints, and CT of the abdomen and pelvis were performed.- Published
- 2024
- Full Text
- View/download PDF
7. Proangiogenic properties of complement protein C1q can contribute to endometriosis.
- Author
-
Agostinis C, Toffoli M, Zito G, Balduit A, Pegoraro S, Spazzapan M, Pascolo L, Romano F, Di Lorenzo G, Mangogna A, Santin A, Spedicati B, Valencic E, Girotto G, Ricci G, Kishore U, and Bulla R
- Subjects
- Humans, Female, Endothelial Cells metabolism, Endothelial Cells immunology, Endometrium immunology, Endometrium metabolism, Endometrium pathology, Macrophages immunology, Macrophages metabolism, Cells, Cultured, Adult, Cell Proliferation, Endometriosis metabolism, Endometriosis immunology, Endometriosis pathology, Endometriosis genetics, Complement C1q genetics, Complement C1q metabolism, Neovascularization, Pathologic genetics, Neovascularization, Pathologic immunology
- Abstract
Endometriosis (EM) is defined as the engraftment and proliferation of functional endometrial-like tissue outside the uterine cavity, leading to a chronic inflammatory condition. While the precise etiology of EM remains elusive, recent studies have highlighted the crucial involvement of a dysregulated immune system. The complement system is one of the predominantly altered immune pathways in EM. Owing to its involvement in the process of angiogenesis, here, we have examined the possible role of the first recognition molecule of the complement classical pathway, C1q. C1q plays seminal roles in several physiological and pathological processes independent of complement activation, including tumor growth, placentation, wound healing, and angiogenesis. Gene expression analysis using the publicly available data revealed that C1q is expressed at higher levels in EM lesions compared to their healthy counterparts. Immunohistochemical analysis confirmed the presence of C1q protein, being localized around the blood vessels in the EM lesions. CD68
+ macrophages are the likely producer of C1q in the EM lesions since cultured EM cells did not produce C1q in vitro . To explore the underlying reasons for increased C1q expression in EM, we focused on its established pro-angiogenic role. Employing various angiogenesis assays on primary endothelial endometriotic cells, such as migration, proliferation, and tube formation assays, we observed a robust proangiogenic effect induced by C1q on endothelial cells in the context of EM. C1q promoted angiogenesis in endothelial cells isolated from EM lesions (as well as healthy ovary that is also rich in C1q). Interestingly, endothelial cells from EM lesions seem to overexpress the receptor for the globular heads of C1q (gC1qR), a putative C1q receptor. Experiments with siRNA to silence gC1qR resulted in diminished capacity of C1q to perform its angiogenic functions, suggesting that C1q is likely to engage gC1qR in the pathophysiology of EM. gC1qR can be a potential therapeutic target in EM patients that will disrupt C1q-mediated proangiogenic activities in EM., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision., (Copyright © 2024 Agostinis, Toffoli, Zito, Balduit, Pegoraro, Spazzapan, Pascolo, Romano, Di Lorenzo, Mangogna, Santin, Spedicati, Valencic, Girotto, Ricci, Kishore and Bulla.)- Published
- 2024
- Full Text
- View/download PDF
8. Systematic review of the complement components as potential biomarkers of pre-eclampsia: pitfalls and opportunities.
- Author
-
Balduit A, Agostinis C, Mangogna A, Zito G, Stampalija T, Ricci G, and Bulla R
- Subjects
- Humans, Pregnancy, Female, Complement Activation, Pre-Eclampsia blood, Pre-Eclampsia immunology, Pre-Eclampsia diagnosis, Biomarkers blood, Complement System Proteins metabolism, Complement System Proteins immunology, Complement System Proteins analysis
- Abstract
The complement system (C) is a crucial component of the innate immune system. An increasing body of research has progressively shed light on the pivotal role of C in immunological tolerance at the feto-maternal interface. Excessive C activation or impaired C regulation may determine the onset of pregnancy-related pathological conditions, including pre-eclampsia (PE). Thus, several studies have investigated the presence of C components or split products in blood matrixes ( i.e. , plasma, serum), urine, and amniotic fluid in PE. In the current study, we systematically reviewed the currently available scientific literature reporting measurements of C components as circulating biomarkers in PE, based on a literature search using Pubmed, Scopus, and Embase databases. A total of 41 out of 456 studies were selected after full-text analysis. Fourteen studies (34.1%) were identified as measuring the blood concentrations of the classical pathway, 5 (12.1%) for the lectin pathway, 28 (68.3%) for the alternative pathway, 17 (41.5%) for the terminal pathway components, and 16 (39%) for C regulators. Retrieved results consistently reported C4, C3, and factor H reduction, and increased circulating levels of C4d, Bb, factor D, C3a, C5a, and C5b-9 in PE compared to normal pregnancies, depicting an overall scenario of excessive C activation and aberrant C regulation. With evidence of C activation and dysregulation, C-targeted therapy is an intriguing perspective in PE management. Moreover, we also discussed emerging pitfalls in C analysis, mainly due to a lack of experimental uniformity and biased cohort selection among different studies and laboratories, aiming to raise a more comprehensive awareness for future standardization., Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42024503070., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision., (Copyright © 2024 Balduit, Agostinis, Mangogna, Zito, Stampalija, Ricci and Bulla.)
- Published
- 2024
- Full Text
- View/download PDF
9. Case 328.
- Author
-
Agostinis C and Lupi E
- Subjects
- Humans, Female, Middle Aged, Diagnosis, Differential, Tomography, X-Ray Computed methods, Magnetic Resonance Imaging methods, Low Back Pain diagnostic imaging, Low Back Pain drug therapy, Low Back Pain etiology
- Abstract
History: A 45-year-old female patient with diffuse osteoarticular pain, particularly low back pain, was referred by a rheumatologist for an updated radiologic evaluation. The patient had experienced these symptoms for many years and was diagnosed with human leukocyte antigen B27-negative spondyloarthritis approximately 11 years prior, based on findings of bilateral erosive sacroiliitis at pelvic radiography (Fig 1A) and bone scintigraphy with technetium 99m methylene diphosphonate (Fig 1B). After 3 years of treatment with a tumor necrosis factor-α inhibitor (adalimumab), which was effective for pain, the patient was lost to follow-up. At the current presentation, approximately 8 years after being lost to follow-up, the patient presented with worsening low back pain. The presence of nonobstructing kidney stones on US images confounded the underlying cause of worsening pain. The patient also experienced fatigue and depressed mood. Routine blood tests revealed a normal blood cell count, creatinine level of 0.64 mg/dL (56.58 μmol/L) (normal range, 0.30-1.1 mg/dL [26.52-97.24 mmol/L]), C-reactive protein level of 1.1 mg/dL (normal, <1 mg/dL), and vitamin D level of 21 ng/mL (52.42 nmol/L) (normal range, 30-100 ng/mL [74.88-249.60 nmol/L]). Noncontrast MRI of the thoracic and lumbar spine (Fig 2), MRI of the sacroiliac joints (Fig 3), and CT of the abdomen and pelvis (Fig 4) were performed.
- Published
- 2024
- Full Text
- View/download PDF
10. Protective role of complement factor H against the development of preeclampsia.
- Author
-
Yasmin H, Agostinis C, Toffoli M, Roy T, Pegoraro S, Balduit A, Zito G, Di Simone N, Ricci G, Madan T, Kishore U, and Bulla R
- Subjects
- Female, Humans, Pregnancy, Complement Factor H metabolism, Endothelial Cells metabolism, Trophoblasts metabolism, Placenta metabolism, Pre-Eclampsia metabolism
- Abstract
Pregnancy is an immunologically regulated, complex process. A tightly controlled complement system plays a crucial role in the successful establishment of pregnancy and parturition. Complement inhibitors at the feto-maternal interface are likely to prevent inappropriate complement activation to protect the fetus. In the present study, we aimed to understand the role of Factor H (FH), a negative regulator of complement activation, in normal pregnancy and in a model of pathological pregnancy, i.e. preeclampsia (PE). The distribution and expression of FH was investigated in placental tissues, various placental cells, and in the sera of healthy (CTRL) or PE pregnant women via immunohistochemistry, RT-qPCR, ELISA, and Western blot. Our results showed a differential expression of FH among the placental cell types, decidual stromal cells (DSCs), decidual endothelial cells (DECs), and extravillous trophoblasts (EVTs). Interestingly, FH was found to be considerably less expressed in the placental tissues of PE patients compared to normal placental tissue both at mRNA and protein levels. Similar results were obtained by measuring circulating FH levels in the sera of third trimester CTRL and PE mothers. Syncytiotrophoblast microvesicles, isolated from the placental tissues of PE and CTRL women, downregulated FH expression by DECs. The present study appears to suggest that FH is ubiquitously present in the normal placenta and plays a homeostatic role during pregnancy., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision., (Copyright © 2024 Yasmin, Agostinis, Toffoli, Roy, Pegoraro, Balduit, Zito, Di Simone, Ricci, Madan, Kishore and Bulla.)
- Published
- 2024
- Full Text
- View/download PDF
11. First Trimester CD93 as a Novel Marker of Preeclampsia and Its Complications: A Pilot Study.
- Author
-
Piani F, Tossetta G, Fantone S, Agostinis C, Di Simone N, Mandalà M, Bulla R, Marzioni D, and Borghi C
- Subjects
- Female, Humans, Infant, Newborn, Pregnancy, Biomarkers, Blood Pressure, Case-Control Studies, Pilot Projects, Pregnancy Trimester, First, Hypertension, Pre-Eclampsia diagnosis
- Abstract
Introduction: CD93 plays a crucial role in endothelial homeostasis and angiogenesis. Recently its role in hypertension has been investigated, holding promise for novel targeted diagnostic and therapeutic strategies., Aim: We assessed for the first time differences in first trimester serum CD93 levels in women who lately developed preeclampsia (PE) vs. normotensive pregnancy (NP)., Methods: First trimester serum CD93 concentrations were assessed in a multicenter cohort of 83 women (34 PE and 49 NP) by ELISA Immunoassay., Results: Serum CD93 was lower in women who developed PE vs. NP (111.8 ± 24.4 vs. 137.5 ± 22.3 ng/ml; p < 0.001). Serum CD93 was associated with a decreased risk of developing PE (OR 0.950, 95% CI 0.922-0.978) and composite neonatal outcome (OR 0.952, CI 0.923-0.982), after adjustment for confounders., Conclusions: PE is accompanied by decreased serum CD93 levels. CD93 might play a role during placentation leading to defective angiogenesis, vascular dysfunction, and PE development., (© 2023. Italian Society of Hypertension.)
- Published
- 2023
- Full Text
- View/download PDF
12. The last word on COVID-19 vaccines and breastfeeding?
- Author
-
Balduit A, Bulla R, and Agostinis C
- Abstract
Competing Interests: Declaration of interests The authors declare no conflict of interest.
- Published
- 2023
- Full Text
- View/download PDF
13. Morphological and lipid metabolism alterations in macrophages exposed to model environmental nanoplastics traced by high-resolution synchrotron techniques.
- Author
-
Zingaro F, Gianoncelli A, Ceccone G, Birarda G, Cassano D, La Spina R, Agostinis C, Bonanni V, Ricci G, and Pascolo L
- Subjects
- Humans, Animals, Female, Pregnancy, Synchrotrons, Macrophages, Microscopy, Fluorescence, Mammals, Microplastics, Lipid Metabolism
- Abstract
The release of nanoplastics (NPs) in the environment is a significant health concern for long-term exposed humans. Although their usage has certainly revolutionized several application fields, at nanometer size, NPs can easily interact at the cellular level, resulting in potential harmful effects. Micro/Nanoplastics (M/NPs) have a demonstrated impact on mammalian endocrine components, such as the thyroid, adrenal gland, testes, and ovaries, while more investigations on prenatal and postnatal exposure are urgently required. The number of literature studies on the NPs' presence in biological samples is increasing. However, only a few offer a close study on the model environmental NP-immune system interaction exploited by advanced microscopy techniques. The present study highlights substantial morphological and lipid metabolism alterations in human M1 macrophages exposed to labeled polypropylene and polyvinyl chloride nanoparticles (PP and PVC NPs) (20 μg/ml). The results are interpreted by advanced microscopy techniques combined with standard laboratory tests and fluorescence microscopy. We report the accurate detection of polymeric nanoparticles doped with cadmium selenide quantum dots (CdSe-QDs NPs) by following the Se (L line) X-ray fluorescence emission peak at higher sub-cellular resolution, compared to the supportive light fluorescence microscopy. In addition, scanning transmission X-ray microscopy (STXM) imaging successfully revealed morphological changes in NP-exposed macrophages, providing input for Fourier transform infrared (FTIR) spectroscopy analyses, which underlined the chemical modifications in macromolecular components, specifically in lipid response. The present evidence was confirmed by quantifying the lipid droplet (LD) contents in PP and PVC NPs-exposed macrophages (0-100 μg/ml) by Oil Red O staining. Hence, even at experimental NPs' concentrations and incubation time, they do not significantly affect cell viability; they cause an evident lipid metabolism impairment, a hallmark of phagocytosis and oxidative stress., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Zingaro, Gianoncelli, Ceccone, Birarda, Cassano, La Spina, Agostinis, Bonanni, Ricci and Pascolo.)
- Published
- 2023
- Full Text
- View/download PDF
14. A likely association between low mannan-binding lectin level and brain fog onset in long COVID patients.
- Author
-
Bulla R, Rossi L, Furlanis G, Agostinis C, Toffoli M, Balduit A, Mangogna A, Liccari M, Morosini G, Kishore U, and Manganotti P
- Subjects
- Humans, Brain, Lectins, Quality of Life, SARS-CoV-2, COVID-19 complications, Mannose-Binding Lectin genetics, Post-Acute COVID-19 Syndrome complications, Mental Fatigue etiology
- Abstract
Brain fog can be described as a constellation of new-onset neuropsychiatric sequelae in the post-acute phase of COVID-19 (long COVID). The symptoms include inattention, short-term memory loss, and reduced mental acuity, which may undermine cognition, concentration, and sleep. This cognitive impairment, persisting for weeks or months after the acute phase of SARS-CoV-2 infection, can significantly impact on daily activities and the quality of life. An important role for the complement system (C) in the pathogenesis of COVID-19 has emerged since the beginning of pandemic outbreak. A number of pathophysiological characteristics including microangiopathy and myocarditis have been attributed to dysregulated C activation due to SARS-CoV-2 infection. Mannan-binding lectin (MBL), the first recognition subcomponent of the C lectin pathway, has been shown to bind to glycosylated SARS-CoV-2 spike protein, genetic variants of MBL2 are suggested to have an association with severe COVID-19 manifestations requiring hospitalization. In the present study, we evaluated MBL activity (lectin pathway activation) and levels in the sera of a cohort of COVID-19 patients, presenting brain fog or only hyposmia/hypogeusia as persistent symptoms, and compared them with healthy volunteers. We found significantly lower levels of MBL and lectin pathway activity in the sera of patients experiencing brain fog as compared to recovered COVID-19 patients without brain fog. Our data indicate that long COVID-associated brain fog can be listed among the variegate manifestations of increased susceptibility to infections and diseases contributed by MBL deficiency., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Bulla, Rossi, Furlanis, Agostinis, Toffoli, Balduit, Mangogna, Liccari, Morosini, Kishore and Manganotti.)
- Published
- 2023
- Full Text
- View/download PDF
15. Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma.
- Author
-
Balduit A, Vidergar R, Zacchi P, Mangogna A, Agostinis C, Grandolfo M, Bottin C, Salton F, Confalonieri P, Rocca A, Zanconati F, Confalonieri M, Kishore U, Ghebrehiwet B, and Bulla R
- Subjects
- Humans, Complement C1q metabolism, Membrane Glycoproteins metabolism, Tumor Microenvironment, Carrier Proteins, Mitochondrial Proteins genetics, Hyaluronic Acid metabolism, Mesothelioma, Malignant
- Abstract
Complement component C1q can act as a pro-tumorigenic factor in the tumor microenvironment (TME). The TME in malignant pleural mesothelioma (MPM) is rich in C1q and hyaluronic acid (HA), whose interaction enhances adhesion, migration and proliferation of malignant cells. HA-bound C1q is also capable of modulating HA synthesis. Thus, we investigated whether HA-C1q interaction would affect HA degradation, analyzing the main degradation enzymes, hyaluronidase (HYAL)1 and HYAL2, and a C1q receptor candidate. We first proceeded with the characterization of HYALs in MPM cells, especially HYAL2, since bioinformatics survival analysis revealed that higher HYAL2 mRNA levels have an unfavorable prognostic index in MPM patients. Interestingly, Real-Time quantitative PCR, flow cytometry and Western blot highlighted an upregulation of HYAL2 after seeding of primary MPM cells onto HA-bound C1q. In an attempt to unveil the receptors potentially involved in HA-C1q signaling, a striking co-localization between HYAL2 and globular C1q receptor/HABP1/p32 (gC1qR) was found by immunofluorescence, surface biotinylation and proximity ligation assays. RNA interference experiments revealed a potentially regulatory function exerted by gC1qR on HYAL2 expression, since C1QBP (gene for gC1qR) silencing unexpectedly caused HYAL2 downregulation. In addition, the functional blockage of gC1qR by a specific antibody hindered HA-C1q signaling and prevented HYAL2 upregulation. Thus, C1q-HA interplay is responsible for enhanced HYAL2 expression, suggesting an increased rate of HA catabolism and the release of pro-inflammatory and pro-tumorigenic HA fragments in the MPM TME. Our data support the notion of an overall tumor-promoting property of C1q. Moreover, the overlapping localization and physical interaction between HYAL2 and gC1qR suggests a potential regulatory effect of gC1qR within a putative HA-C1q macromolecular complex., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Balduit, Vidergar, Zacchi, Mangogna, Agostinis, Grandolfo, Bottin, Salton, Confalonieri, Rocca, Zanconati, Confalonieri, Kishore, Ghebrehiwet and Bulla.)
- Published
- 2023
- Full Text
- View/download PDF
16. Genetic bases of C7 deficiency: systematic review and report of a novel deletion determining functional hemizygosity.
- Author
-
Balduit A, Bianco AM, Mangogna A, Zicari AM, Leonardi L, Cinicola BL, Capponi M, Tommasini A, Agostinis C, d'Adamo AP, and Bulla R
- Subjects
- Male, Humans, Child, 3' Untranslated Regions, Alleles, Autoimmunity, Biological Assay
- Abstract
Primary complement system (C) deficiencies are rare but notably associated with an increased risk of infections, autoimmunity, or immune disorders. Patients with terminal pathway C-deficiency have a 1,000- to 10,000-fold-higher risk of Neisseria meningitidis infections and should be therefore promptly identified to minimize the likelihood of further infections and to favor vaccination. In this paper, we performed a systematic review about clinical and genetic patterns of C7 deficiency starting from the case of a ten-year old boy infected by Neisseria meningitidis B and with clinical presentation suggestive of reduced C activity. Functional assay via Wieslab ELISA Kit confirmed a reduction in total C activity of the classical (0.6% activity), lectin (0.2% activity) and alternative (0.1% activity) pathways. Western blot analysis revealed the absence of C7 in patient serum. Sanger sequencing of genomic DNA extracted from peripheral blood of the patient allowed the identification of two pathogenetic variants in the C7 gene: the already well-characterized missense mutation G379R and a novel heterozygous deletion of three nucleotides located at the 3'UTR (c.*99_*101delTCT). This mutation resulted in an instability of the mRNA; thus, only the allele containing the missense mutation was expressed, making the proband a functional hemizygote for the expression of the mutated C7 allele., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Balduit, Bianco, Mangogna, Zicari, Leonardi, Cinicola, Capponi, Tommasini, Agostinis, d’Adamo and Bulla.)
- Published
- 2023
- Full Text
- View/download PDF
17. Anti-Spike Antibodies Present in the Milk of SARS-CoV-2 Vaccinated Mothers Are Complement-Activating.
- Author
-
Agostinis C, Toffoli M, Balduit A, Mangogna A, Yasmin H, Ragazzon C, Pegoraro S, Campisciano G, Stabile G, Zito G, Kishore U, Comar M, Scrimin F, Bulla R, and Ricci G
- Subjects
- Infant, Newborn, Infant, Female, Humans, COVID-19 Vaccines, Lactation, Milk, Human, Complement System Proteins, Immunoglobulin G, Antibodies, Viral, SARS-CoV-2, COVID-19
- Abstract
Although only 0.8-1% of SARS-CoV-2 infections are in the 0-9 age-group, pneumonia is still the leading cause of infant mortality globally. Antibodies specifically directed against SARS-CoV-2 spike protein (S) are produced during severe COVID-19 manifestations. Following vaccination, specific antibodies are also detected in the milk of breastfeeding mothers. Since antibody binding to viral antigens can trigger activation of the complement classical - pathway, we investigated antibody-dependent complement activation by anti-S immunoglobulins (Igs) present in breast milk following SARS-CoV-2 vaccination. This was in view of the fact that complement could play a fundamentally protective role against SARS-CoV-2 infection in newborns. Thus, 22 vaccinated, lactating healthcare and school workers were enrolled, and a sample of serum and milk was collected from each woman. We first tested for the presence of anti-S IgG and IgA in serum and milk of breastfeeding women by ELISA. We then measured the concentration of the first subcomponents of the three complement pathways (i.e., C1q, MBL, and C3) and the ability of anti-S Igs detected in milk to activate the complement in vitro. The current study demonstrated that vaccinated mothers have anti-S IgG in serum as well as in breast milk, which is capable of activating complement and may confer a protective benefit to breastfed newborns.
- Published
- 2023
- Full Text
- View/download PDF
18. Ischemic wound revascularization by the stromal vascular fraction relies on host-donor hybrid vessels.
- Author
-
Vuerich R, Groppa E, Vodret S, Ring NAR, Stocco C, Bossi F, Agostinis C, Cauteruccio M, Colliva A, Ramadan M, Simoncello F, Benvenuti F, Agnelli A, Dore F, Mazzarol F, Moretti M, Paulitti A, Palmisano S, De Manzini N, Chiesa M, Casaburo M, Raucci A, Lorizio D, Pompilio G, Bulla R, Papa G, and Zacchigna S
- Abstract
Nonhealing wounds place a significant burden on both quality of life of affected patients and health systems. Skin substitutes are applied to promote the closure of nonhealing wounds, although their efficacy is limited by inadequate vascularization. The stromal vascular fraction (SVF) from the adipose tissue is a promising therapy to overcome this limitation. Despite a few successful clinical trials, its incorporation in the clinical routine has been hampered by their inconsistent results. All these studies concluded by warranting pre-clinical work aimed at both characterizing the cell types composing the SVF and shedding light on their mechanism of action. Here, we established a model of nonhealing wound, in which we applied the SVF in combination with a clinical-grade skin substitute. We purified the SVF cells from transgenic animals to trace their fate after transplantation and observed that it gave rise to a mature vascular network composed of arteries, capillaries, veins, as well as lymphatics, structurally and functionally connected with the host circulation. Then we moved to a human-in-mouse model and confirmed that SVF-derived endothelial cells formed hybrid human-mouse vessels, that were stabilized by perivascular cells. Mechanistically, SVF-derived endothelial cells engrafted and expanded, directly contributing to the formation of new vessels, while a population of fibro-adipogenic progenitors stimulated the expansion of the host vasculature in a paracrine manner. These data have important clinical implications, as they provide a steppingstone toward the reproducible and effective adoption of the SVF as a standard care for nonhealing wounds., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
19. A longitudinal study of C1q and anti-C1q autoantibodies in homologous and heterologous pregnancies for predicting pre-eclampsia.
- Author
-
Agostinis C, Zito G, Toffoli M, Peterlunger I, Simoni L, Balduit A, Curtolo E, Mangogna A, Belmonte B, Vacca D, Romano F, Stampalija T, Salviato T, Defendi F, Di Simone N, Kishore U, Ricci G, and Bulla R
- Subjects
- Female, Humans, Pregnancy, Autoantibodies, Complement C1q, Longitudinal Studies, Placenta metabolism, Pre-Eclampsia
- Abstract
C1q, the recognition molecule of the classical pathway of the complement system, plays a central role in pregnancy. Lack of C1q is characterized by poor trophoblast invasion and pregnancy failure. C1q can be the target of an antibody response: anti-C1q autoantibodies (anti-C1q) are present in several infectious and autoimmune diseases. The presence of these autoantibodies has been detected also in 2-8% of the general population. Recent evidence indicates that women who undergo assisted reproductive technology (ART) have an increased risk of developing pre-eclampsia (PE), particularly oocyte donation (OD) pregnancies. The aim of this study was to characterize the levels of C1q and anti-C1q in PE gestations, in healthy spontaneous, homologous and heterologous ART pregnancies. Serum of the following four groups of women, who were followed throughout two or three trimesters, were collected: PE, patients diagnosed with PE; OD, oocyte donation recipients; HOM, homologous ART women; Sp, spontaneous physiological pregnancy. Our results indicate that PE patients have lower levels of anti-C1q. In ART pregnant women, the trend of C1q and anti-C1q levels were similar to PE patients, even though these women did not develop PE-like symptoms during pregnancy. This finding suggests an immunological dysfunction at the foetal-maternal interface in ART pregnancies, a hypothesis confirmed by the observation of C1q deposition in placentae derived from OD, comparable to PE. Since significantly lower levels of anti-C1q were detected in PE compared to healthy control sera, we hypothesize the possible binding on placental syncytiotrophoblast microvesicles (STBM), which are increased in the circulation of PE mothers. Furthermore, the characterization of the binding-epitope of anti-C1q revealed that "physiological" autoantibodies were mainly directed against C1q globular domain. We concluded that anti-C1q could have a physiological role in pregnancy: during the healthy spontaneous pregnancy the raised levels of these autoantibodies can be important for the clearance of STBM. In PE and in pathological pregnancies (but also in OD pregnancies), the increase in syncytiotrophoblast apoptosis and consequent increase of the circulating STMB levels lead to a consumption of C1q and anti-C1q., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Agostinis, Zito, Toffoli, Peterlunger, Simoni, Balduit, Curtolo, Mangogna, Belmonte, Vacca, Romano, Stampalija, Salviato, Defendi, Di Simone, Kishore, Ricci and Bulla.)
- Published
- 2022
- Full Text
- View/download PDF
20. SARS-CoV-2 modulates virus receptor expression in placenta and can induce trophoblast fusion, inflammation and endothelial permeability.
- Author
-
Agostinis C, Toffoli M, Spazzapan M, Balduit A, Zito G, Mangogna A, Zupin L, Salviato T, Maiocchi S, Romano F, Crovella S, Fontana F, Braga L, Confalonieri M, Ricci G, Kishore U, and Bulla R
- Subjects
- Angiotensin-Converting Enzyme 2, Cytokines metabolism, Female, Humans, Inflammation metabolism, Permeability, Placenta metabolism, Placenta virology, Pre-Eclampsia metabolism, Pregnancy, Premature Birth metabolism, SARS-CoV-2, Spike Glycoprotein, Coronavirus metabolism, Trophoblasts, COVID-19 complications, Pregnancy Complications, Infectious virology, Receptors, Virus metabolism
- Abstract
SARS-CoV-2 is a devastating virus that induces a range of immunopathological mechanisms including cytokine storm, apoptosis, inflammation and complement and coagulation pathway hyperactivation. However, how the infection impacts pregnant mothers is still being worked out due to evidence of vertical transmission of the SARS-CoV-2, and higher incidence of pre-eclampsia, preterm birth, caesarian section, and fetal mortality. In this study, we assessed the levels of the three main receptors of SARS-CoV-2 (ACE2, TMPRSS2 and CD147) in placentae derived from SARS-CoV-2 positive and negative mothers. Moreover, we measured the effects of Spike protein on placental cell lines, in addition to their susceptibility to infection. SARS-CoV-2 negative placentae showed elevated levels of CD147 and considerably low amount of TMPRSS2, making them non-permissive to infection. SARS-CoV-2 presence upregulated TMPRSS2 expression in syncytiotrophoblast and cytotrophoblast cells, thereby rendering them amenable to infection. The non-permissiveness of placental cells can be due to their less fusogenicity due to infection. We also found that Spike protein was capable of inducing pro-inflammatory cytokine production, syncytiotrophoblast apoptosis and increased vascular permeability. These events can elicit pre-eclampsia-like syndrome that marks a high percentage of pregnancies when mothers are infected with SARS-CoV-2. Our study raises important points relevant to SARS-CoV-2 mediated adverse pregnancy outcomes., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Agostinis, Toffoli, Spazzapan, Balduit, Zito, Mangogna, Zupin, Salviato, Maiocchi, Romano, Crovella, Fontana, Braga, Confalonieri, Ricci, Kishore and Bulla.)
- Published
- 2022
- Full Text
- View/download PDF
21. Editor's Note: Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts.
- Author
-
Voltan R, Secchiero P, Ruozi B, Forni F, Agostinis C, Caruso L, Vandelli MA, and Zauli G
- Published
- 2022
- Full Text
- View/download PDF
22. Distinct Roles of Classical and Lectin Pathways of Complement in Preeclamptic Placentae.
- Author
-
Belmonte B, Mangogna A, Gulino A, Cancila V, Morello G, Agostinis C, Bulla R, Ricci G, Fraggetta F, Botto M, Garred P, and Tedesco F
- Subjects
- Animals, Complement C1q metabolism, Complement System Proteins metabolism, Endothelial Cells metabolism, Female, Humans, Lectins metabolism, Male, Mannose-Binding Protein-Associated Serine Proteases metabolism, Mice, Placenta metabolism, Pregnancy, Vascular Remodeling, Pre-Eclampsia metabolism
- Abstract
Pre-eclampsia is a pregnancy complication characterized by defective vascular remodeling in maternal decidua responsible for reduced blood flow leading to functional and structural alterations in the placenta. We have investigated the contribution of the complement system to decidual vascular changes and showed that trophoblasts surrounding unremodeled vessels prevalent in preeclamptic decidua fail to express C1q that are clearly detected in cells around remodeled vessels predominant in control placenta. The critical role of C1q is supported by the finding that decidual trophoblasts of female C1qa
-/- pregnant mice mated to C1qa+/+ male mice surrounding remodeled vessels express C1q of paternal origin. Unlike C1qa-/- pregnant mice, heterozygous C1qa+/- and wild type pregnant mice share a high percentage of remodeled vessels. C1q was also found in decidual vessels and stroma of normal placentae and the staining was stronger in preeclamptic placentae. Failure to detect placental deposition of C1r and C1s associated with C1q rules out complement activation through the classical pathway. Conversely, the intense staining of decidual endothelial cells and villous trophoblast for ficolin-3, MASP-1 and MASP-2 supports the activation of the lectin pathway that proceeds with the cleavage of C4 and C3 and the assembly of the terminal complex. These data extend to humans our previous findings of complement activation through the lectin pathway in an animal model of pre-eclampsia and provide evidence for an important contribution of C1q in decidual vascular remodeling., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Belmonte, Mangogna, Gulino, Cancila, Morello, Agostinis, Bulla, Ricci, Fraggetta, Botto, Garred and Tedesco.)- Published
- 2022
- Full Text
- View/download PDF
23. At Embryo Implantation Site IL-35 Secreted by Trophoblast, Polarizing T Cells towards IL-35+ IL-10+ IL-4+ Th2-Type Cells, Could Favour Fetal Allograft Tolerance and Pregnancy Success.
- Author
-
Lombardelli L, Logiodice F, Kullolli O, Haller H, Agostinis C, Bulla R, Rukavina D, and Piccinni MP
- Subjects
- Cell Polarity, Cytokines, Decidua, Embryo Implantation, Female, Humans, Interleukin-10, Interleukin-4, Pregnancy, T-Lymphocytes cytology, T-Lymphocytes metabolism, Transplantation Tolerance, Interleukins metabolism, Th2 Cells metabolism, Trophoblasts metabolism
- Abstract
We investigated the role of rhIL-35, at low concentrations compatible with those produced by human trophoblast cells (less than 1 ng/mL), on human T helper (Th) cell functions and the presence of decidual IL-35-producing Th cells in human pregnancy. We found that human trophoblast cells produced IL-35 but not IL-4 or IL-10. RhIL-35, at concentrations produced by human trophoblasts, polarized T cells towards IL-35+, IL-10+, IL-4+ Th2-type cells and to Foxp3+ EBI3+ p35+ T reg cells producing IL-35 but not IL-10 and IL-4. Moreover, rhIL-35 at low concentrations did not suppress the proliferation of Th cells but stimulated IL-4 and IL-10 production by established Th clones. In particular, Th1-type clones acquired the capacity to produce IL-4. In addition, purified human trophoblast cell supernatants containing IL-35 upregulated IL-4 and IL-10 production by Th clones. Finally, IL-35+, IL-10+, IL-4+ Th2-type cells, which were found to be induced by low concentrations of IL-35 compatible with those produced by human trophoblasts, are exclusively present in the decidua of a successful pregnancy and at the embryo implantation site, suggesting their stringent dependence on trophoblast cells. Thus, the proximity of Th cells to IL-35-producing trophoblasts could be the determining factor for the differentiation of IL-35+, IL-10+, IL-4+ Th2-type cells that are crucial for human pregnancy success.
- Published
- 2022
- Full Text
- View/download PDF
24. COVID-19, Pre-Eclampsia, and Complement System.
- Author
-
Agostinis C, Mangogna A, Balduit A, Aghamajidi A, Ricci G, Kishore U, and Bulla R
- Subjects
- COVID-19 physiopathology, Complement Inactivator Proteins therapeutic use, Endothelium immunology, Female, Humans, Pre-Eclampsia physiopathology, Pre-Eclampsia prevention & control, Pregnancy, Pregnancy Complications, Infectious drug therapy, Pregnancy Complications, Infectious physiopathology, SARS-CoV-2, Thrombosis immunology, COVID-19 Drug Treatment, COVID-19 immunology, Complement System Proteins immunology, Pre-Eclampsia immunology, Pregnancy Complications, Infectious immunology
- Abstract
COVID-19 is characterized by virus-induced injury leading to multi-organ failure, together with inflammatory reaction, endothelial cell (EC) injury, and prothrombotic coagulopathy with thrombotic events. Complement system (C) via its cross-talk with the contact and coagulation systems contributes significantly to the severity and pathological consequences due to SARS-CoV-2 infection. These immunopathological mechanisms overlap in COVID-19 and pre-eclampsia (PE). Thus, mothers contracting SARS-CoV-2 infection during pregnancy are more vulnerable to developing PE. SARS-CoV-2 infection of ECs, via its receptor ACE2 and co-receptor TMPRSS2, can provoke endothelial dysfunction and disruption of vascular integrity, causing hyperinflammation and hypercoagulability. This is aggravated by bradykinin increase due to inhibition of ACE2 activity by the virus. C is important for the progression of normal pregnancy, and its dysregulation can impact in the form of PE-like syndrome as a consequence of SARS-CoV-2 infection. Thus, there is also an overlap between treatment regimens of COVID-19 and PE. C inhibitors, especially those targeting C3 or MASP-2, are exciting options for treating COVID-19 and consequent PE. In this review, we examine the role of C, contact and coagulation systems as well as endothelial hyperactivation with respect to SARS-CoV-2 infection during pregnancy and likely development of PE., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Agostinis, Mangogna, Balduit, Aghamajidi, Ricci, Kishore and Bulla.)
- Published
- 2021
- Full Text
- View/download PDF
25. Differential Capability of Clinically Employed Dermal Regeneration Scaffolds to Support Vascularization for Tissue Bioengineering.
- Author
-
Agostinis C, Spazzapan M, Vuerich R, Balduit A, Stocco C, Mangogna A, Ricci G, Papa G, Zacchigna S, and Bulla R
- Abstract
The loss of skin integrity has always represented a major challenge for clinicians dealing with dermal defects, such as ulcers (diabetic, vascular and chronic), postoncologic resections (i.e., radical vulvectomy) or dermatologic disorders. The introduction in recent decades of acellular dermal matrices (ADMs) supporting the repair and restoration of skin functionality represented a significant step toward achieving clean wound repair before performing skin grafts. Hard-to-heal ulcers generally depend on local ischemia and nonadequate vascularization. In this context, one possible innovative approach could be the prevascularization of matrices with vessel-forming cells (inosculation). This paper presents a comparative analysis of the most widely used dermal templates, i.e., Integra
® Bilayer Matrix Wound Dressing, PELNAC® , PriMatrix® Dermal Repair Scaffold, Endoform® Natural Dermal Template, and Myriad Matrix® , testing their ability to be colonized by human adult dermal microvascular endothelial cells (ADMECs) and to induce and support angiogenesis in vitro and in vivo. By in vitro studies, we demonstrated that Integra® and PELNAC® possess superior pro-adhesive and pro-angiogenetic properties. Animal models allowed us to demonstrate the ability of preseeded ADMECs on Integra® to promote the engraftment, integration and vascularization of ADMs at the site of application.- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.